Drug Shortage Report for TEVA-RAMIPRIL

Last updated on 2024-11-01 History
Report ID 234882
Drug Identification Number 02247945
Brand name TEVA-RAMIPRIL
Common or Proper name RAMIPRIL 2.5MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RAMIPRIL
Strength(s) 2.5MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size PP 30
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-08-07
Estimated end date 2024-10-31
Actual end date 2024-10-31
Shortage status Resolved
Updated date 2024-11-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-11-01 French Compare
v9 2024-11-01 English Compare
v8 2024-10-24 French Compare
v7 2024-10-24 English Compare
v6 2024-09-19 French Compare
v5 2024-09-19 English Compare
v4 2024-09-05 French Compare
v3 2024-09-05 English Compare
v2 2024-08-08 French Compare
v1 2024-08-08 English Compare

Showing 1 to 10 of 10